Meta AnalysisID 1517

补充肌肽或β-丙氨酸对人类和动物研究中血糖控制及胰岛素抵抗标志物的影响:系统评价与Meta分析方案

CRD42020191588

What is the effect of carnosine or beta-alanine supplementation on markers of glycaemic control and insulin resistance in humans and animals?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
1517
Evidence Id
10075
Core Evidence Id
10075
Source Meta Analysis Id
1472
Herb2 Meta Analysis Id
HBMA001472
Crd Id
CRD42020191588
Title
The effect of carnosine or beta-alanine supplementation on markers of glycaemic control and insulin resistance in human and animal studies: a protocol for a systematic review and meta-analysis
Review Question
What is the effect of carnosine or beta-alanine supplementation on markers of glycaemic control and insulin resistance in humans and animals?
Study Type Included
Studies will be limited to non-randomised and randomised controlled trials (RCTs), including cluster RCTs. We will exclude cohort studies, cross-sectional studies, case series, case reports, commentary, and review articles.
Condition Being Studied
Glycaemic control and insulin resistance.
Participant
Humans with a diagnosis of type 1 diabetes, type 2 diabetes, prediabetes, gestational diabetes, impaired fasting glucose, or impaired glucose tolerance (according to World Health Organization guidelines); or humans with overweight/obesity (body mass index equal to or greater than 25 kg/m2) where the relevant outcomes were collected and reported. Animal studies with a relevant disease model (see criteria above). There will be no restriction on age or comorbidities; and no restrictions on the methods used to induce disease in animal studies.
Animal
Human Disease Modelled
Intervention
Supplementation with carnosine or beta-alanine. We will exclude studies that use a multi-ingredient supplement intervention. Human studies will include oral administration only, whereas in animal studies we will also consider administration by other means (e.g., intraperitoneal or intravenous injection).
Comparator Control
Comparisons for human studies will be between placebo and the experimental intervention. Comparisons for animal studies will be between placebo or control (no intervention) and the experimental intervention. Studies without a control or placebo group will be excluded.
Main Outcome
Primary outcomes include: 1) fasting glucose; 2) glycated haemoglobin, and 3) 2-hour glucose following a glucose tolerance test. Measures of effect Raw scale mean difference between intervention and control/placebo.
Outcome Measure
Additional Outcome
Markers of glycaemic control and insulin resistance (e.g., fasting insulin, glucose tolerance test parameters, homeostatic model assessment parameters). Measures of effect Standardised mean difference between intervention and control/placebo.
Study Method
Meta-analysis, Systematic review
Keyword
Animals; Biomarkers; Blood Glucose; Carnosine; Dietary Supplements; Humans; Insulin Resistance; beta-Alanine
Contact
Joseph J Matthews [email protected]
Organisational Affiliation
Nottingham Trent University (NTU).
Funding Source
None.
Other Selection Criteria
Final Publication
https://academic.oup.com/advances/advance-article/doi/10.1093/advances/nmab087/6333366?searchresult=1
Same Topic Review
Published Protocol
Review Type
Language
English
Country
England
Review Stage
Review Completed published
First Submission Date
2020-06-11
Registration Date
2020-07-02
Anticipated Start Date
2020-06-01
Anticipated Completion Date
2021-01-31
Title Cn
补充肌肽或β-丙氨酸对人类和动物研究中血糖控制及胰岛素抵抗标志物的影响:系统评价与Meta分析方案
Title En
The effect of carnosine or beta-alanine supplementation on markers of glycaemic control and insulin resistance in human and animal studies: a protocol for a systematic review and meta-analysis
Bilingual Status
complete